Colorectal carcinoma evidence for circulating CEA–anti‐CEA complexes

Cancer

Volumn 52, Issue 1, 1983, Pages 146-149

  Mavligit, Giora M ^a   Stuckey, Sarah ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN G; RADIOISOTOPE;

ANTIGEN ANTIBODY COMPLEX; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSIS; HUMAN; LARGE INTESTINE; MONITORING; PATIENT;

ANTIGEN-ANTIBODY COMPLEX; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; HUMAN; RECTAL NEOPLASMS;

EID: 0020521290     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19830701)52:1<146::AID-CNCR2820520126>3.0.CO;2-N     Document Type: Article

References (25)

1. Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum
2. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma
3. Sixty second‐look procedures indicated primarily by rise in serial carcinoembryonic antigen
4. Systemic adjuvant therapy with BCG versus BCG + 5‐FU in colorectal cancer Dukes' Class C updated critical analysis
5. Results of CEA‐initiated second‐look surgery for recurrent colorectal cancer
6. Use of CEA as an indicator of early recurrence and as a guide to a selected second‐look procedure in patients with colorectal Cancer
7. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver
8. The use and limitations of serial plasma carcinoembryonic antigen levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy
9. Demonstration of an antigen common to several varieties of neoplasia. Assay using zirconyl phosphate gel
10. Carcinoembryonic antigen test for recurrent colorectal carcinoma
11. The quantitative relationship of carcinoembryonic antigen to tumor cells of different organs
12. Prognostic factors in colon carcinoma
13. Human anti‐CEA antibodies detected by radioimmunoelectrophoresis
14. Further investigation of circulating antibodies in colon cancer patients: On the autoantigenicity of the carcinoembryonic antigen
15. Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies
16. The antigenicity of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies
17. Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?
18. Carcinoembryonic antigen–antibody complexes in a patient with colonic carcinoma and nephrotic syndrome
19. Isolation of soluble immune complexes from serum using protein‐A bearing Staphylococcus aureus bacteria: Separation of the antigen from immune complex and production of antisera
20. Precipitation of radiolabeled antigen‐antibody complexes with protein A‐containing Staphylococcus aureus
21. Using of Staphyloccal Protein A as an immunological reagent
22. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma
23. Presence of immunoglobulin G in human sera binding to carcinoembryonic antigen (CEA) and nonspecific cross‐reacting antigen (NCA)
24. Recovery of immunologically active antigens from Staphylococcal protein A‐antibody adsorbent
25. Monoclonal antibodies to carcinoembryonic antigen produced by somatic cell fusion